OptimizeRx (OPRX) investor relations material

Corporate profile and market position

• Leading technology provider connecting life sciences, physicians, and patients to improve therapy initiation and adherence.

• Operates the largest U.S. patient point-of-care network, reaching most physicians and patients.

• Employs about 130 staff across the U.S. and Croatia, with revenue per FTE exceeding $800K.

• Listed on NASDAQ with a market cap of ~$101M and $20.2M in cash as of Q1 2026.

Strategic challenges and solutions

• Addresses pharma challenges: brand visibility, specialty medication shift, EHR overload, affordability, interoperability, and script abandonment.

• Mission combines human ingenuity, AI, and technology to transform life-science marketing and patient connections.

• Platform connects over 2 million HCPs and 240 million patients, supporting ~400 brands.

Technology and platform capabilities

• Dynamic Audience Activation Platform (DAAP) delivers predictive, privacy-safe marketing across clinical and personal platforms.

• DAAP deals typically range from $0.5M to $1.5M, supporting omnichannel marketing execution.

• First to enable programmatic buying of authenticated EHR inventory at scale, unlocking access to 90% of U.S. digital display spend.